Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ten-Year Clinical Outcomes of Biodegradable Versus Durable Polymer New-Generation Drug-Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus.
Lenz T, Koch T, Joner M, Xhepa E, Wiebe J, Coughlan JJ, Aytekin A, Ibrahim T, Fusaro M, Cassese S, Laugwitz KL, Schunkert H, Kastrati A, Kufner S; ISAR‐TEST 4 (Intracoronary Stenting, Angiographic Results: Test Efficacy of 3 Limus‐Eluting Stents) Investigators †. Lenz T, et al. J Am Heart Assoc. 2021 Jun 15;10(12):e020165. doi: 10.1161/JAHA.120.020165. Epub 2021 Jun 2. J Am Heart Assoc. 2021. PMID: 34075784 Free PMC article. Clinical Trial.
Second-versus first-generation "Limus"-eluting stents in diabetic patients with coronary artery disease: a randomized comparison in setting of ISAR-TEST-4 trial.
Kufner S, Byrne RA, Mehilli J, Massberg S, Birkmeier KA, Schulz S, Pache J, Schömig A, Kastrati A. Kufner S, et al. Among authors: birkmeier ka. Catheter Cardiovasc Interv. 2013 Nov 15;82(6):E769-76. doi: 10.1002/ccd.24741. Epub 2013 Jun 11. Catheter Cardiovasc Interv. 2013. PMID: 23754254 Clinical Trial.
One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial.
Schulz S, Kastrati A, Ferenc M, Massberg S, Birkmeier KA, Laugwitz KL, Kufner S, Gick M, Dommasch M, Schühlen H, Schömig A, Berger PB, Mehilli J, Neumann FJ; Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 4 Trial Investigators. Schulz S, et al. Among authors: birkmeier ka. EuroIntervention. 2013 Aug 22;9(4):430-6. doi: 10.4244/EIJV9I4A71. EuroIntervention. 2013. PMID: 23455033 Free article. Clinical Trial.
Influence of abciximab on evolution of left ventricular function in patients with non-ST-segment elevation acute coronary syndromes undergoing PCI after clopidogrel pretreatment: lessons from the ISAR-REACT 2 trial.
Schulz S, Mehilli J, Ndrepepa G, Dotzer F, Dommasch M, Kufner S, Birkmeier KA, Tiroch K, Byrne RA, Schömig A, Kastrati A. Schulz S, et al. Among authors: birkmeier ka. Clin Res Cardiol. 2011 Aug;100(8):691-9. doi: 10.1007/s00392-011-0299-y. Epub 2011 Mar 8. Clin Res Cardiol. 2011. PMID: 21384174 Clinical Trial.
2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
Byrne RA, Kastrati A, Tiroch K, Schulz S, Pache J, Pinieck S, Massberg S, Seyfarth M, Laugwitz KL, Birkmeier KA, Schömig A, Mehilli J; ISAR-TEST-2 Investigators. Byrne RA, et al. Among authors: birkmeier ka. J Am Coll Cardiol. 2010 Jun 8;55(23):2536-43. doi: 10.1016/j.jacc.2010.03.020. Epub 2010 Apr 22. J Am Coll Cardiol. 2010. PMID: 20417052 Free article. Clinical Trial.
14 results